In recent years, cancer has posed a serious threat to human health. Computer tomography is the most important auxiliary method for diagnosing cancer, and doctors can study the patient's CT images to ...

Lung cancer among never-smokers is rising worldwide. In one U.S. study of 12,000 lung cancer patients, the share of people who didn’t smoke rose from 8 to 15 percent over twenty years.

Lung cancer is one among critical diseases and numerous people are suffering from this disease. Lung cancer is not only caused by smoking cigarettes, pipes or cigars; other risk factors include ...

The treatment of non-small cell lung cancer (NSCLC) primarily relies on chemotherapy following surgical intervention. However, many late-stage NSCLC patients exhibit drug resistance and experience ...

The main difficulty with current anticancer nanotherapeutics comes from the low efficiency of tumor targeting. Although many strategies have been investigated, including cancer-specific antibody ...

The positive CHMP opinion is based on data from the CABINET Phase III trial, which investigated Cabometyx versus placebo in people living with advanced pNETs or epNETs, whose disease had progressed ...

Nineteen (95%) patients with duodenal carcinoid <2.0 cm of tumor size were initially treated with an endoscopic resection of the duodenal lesion. A negative resection margin was achieved in 16 (80%) ...

Taletrectinib (Ibrtrozi) is now an FDA-approved agent for the treatment of locally advanced or metastatic ROS1-positive non–small cell lung cancer (NSCLC). The approval is supported by 2 phase 2 ...

Dive Brief: The Food and Drug Administration has approved a new oral medication for an uncommon kind of tumor, clearing Nuvation Bio’s Ibtrozi on Wednesday for certain people whose metastatic ...